PhRMA comments on BsUFA

List of 2015 Medicines in Development for Heart Disease and Stroke

Data Exclusivity for Biologics

Biosimilars Naming

Biosimilars 101

What makes Valeant different?

Personalized Medicine: Transforming Patient Care

Joint PhRMA - BIO Letter on IPR

PhRMA and Epilepsy Foundation Report More Than 400 Medicines in Development to Treat Neurological Disorders

Washington, D.C. (July 13, 2015) — America’s biopharmaceutical research companies are currently developing 420 medicines for patients suffering from neurological disorders, including epilepsy, Alzheimer’s disease, multiple sclerosis (MS) and Parkinson’s disease.

Neurological drug list

Pages

Subscribe to RSS - Innovation